About 1,925,176 results (1,875 milliseconds)

Cardiovascular Outcomes in Patients Initiating First-Line Treatment ...

https://news.google.com/__i/rss/rd/articles/CBMiMGh0dHBzOi8vd3d3LmFjcGpvdXJuYWxzLm9yZy9kb2kvMTAuNzMyNi9NMjEtNDAxMtIBAA?oc=5/
May 24, 2022 ... HHF = hospitalization for heart failure; MI = myocardial infarction; SGLT-2i = sodium–glucose cotransporter-2 inhibitors. ... Treat Type 2 ...

Development and validation of a model to predict cardiovascular ...

https://news.google.com/__i/rss/rd/articles/CBMiRWh0dHBzOi8vY2FyZGlhYi5iaW9tZWRjZW50cmFsLmNvbS9hcnRpY2xlcy8xMC4xMTg2L3MxMjkzMy0wMjItMDE2MDMtONIBAA?oc=5/
Aug 27, 2022 ... ... (MI), or stroke for individuals with both T2DM and ASCVD. Using data ... Mortality and cardiovascular disease in type 1 and type 2 diabetes.

Sodium–Glucose Cotransporter-2 Inhibitors Versus Glucagon-like ...

https://news.google.com/__i/rss/rd/articles/CBMiMGh0dHBzOi8vd3d3LmFjcGpvdXJuYWxzLm9yZy9kb2kvMTAuNzMyNi9NMjEtMDg5M9IBAA?oc=5
Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 ... GLP-1RA, corresponding to a number needed to treat of 588 patients at two years for ...

The state of diabetes treatment coverage in 55 low-income and ...

https://news.google.com/__i/rss/rd/articles/CBMiUmh0dHBzOi8vd3d3LnRoZWxhbmNldC5jb20vam91cm5hbHMvbGFuaGwvYXJ0aWNsZS9QSUlTMjY2Ni03NTY4KDIxKTAwMDg5LTEvZnVsbHRleHTSAQA?oc=5
May 21, 2021 ... ... Management Research, Ann Arbor, MI, USA ... We estimated self-reported coverage for six core type 2 diabetes clinical treatments recommended in ...

FDA Advisers Narrowly Okay Empagliflozin CV Mortality Claim

http://feedproxy.google.com/~r/Theheartorg/~3/eahgwR02aaw/865523
Jun 29, 2016 ... ... treat type 2 diabetes. The Endocrinologic and Metabolic Drugs ... (MI), or nonfatal stroke (three-point MACE). The trial was to stop ...

Conflicting Data on Sitagliptin and Heart Failure in Diabetes

http://feedproxy.google.com/~r/Theheartorg/~3/DBsq6YSCWxQ/827653
Jul 1, 2014 ... ... (MI), stroke, coronary revascularization, and heart failure associated ... What's the Goal in Treating Type 2 Diabetes? Denosumab for ...

'Extraordinary' Chelation Effects in Diabetes: TACT

http://feedproxy.google.com/~r/Theheartorg/~3/h_9lMb7g3-4/814643
Nov 19, 2013 ... Surprising, Puzzling Benefit From Chelation Therapy After MI ... What's the Goal in Treating Type 2 Diabetes? Denosumab for ...

FIDELITY: Finerenone Cuts CV Risk in T2D Across CKD Spectrum

https://news.google.com/__i/rss/rd/articles/CBMiK2h0dHBzOi8vd3d3Lm1lZHNjYXBlLmNvbS92aWV3YXJ0aWNsZS85NTc0NzDSAQA?oc=5
Aug 28, 2021 ... "Measuring UACR in patients with type 2 diabetes is important to identify patients who will benefit from finerenone treatment independent of ...

Broken PROMISE: CTA for Suspected CAD in Patients With Diabetes

http://feedproxy.google.com/~r/Theheartorg/~3/3fTfxqfm-9A/909852
Mar 5, 2019 ... The main results were neutral: The composite primary endpoint of death, myocardial infarction (MI) ... What's the Goal in Treating Type 2 Diabetes?

Nov 5 2021 This Week in Cardiology

https://news.google.com/__i/rss/rd/articles/CBMiK2h0dHBzOi8vd3d3Lm1lZHNjYXBlLmNvbS92aWV3YXJ0aWNsZS85NjIzMDDSAQA?oc=5
Nov 5, 2021 ... As our ability to diagnosis and treat improves, MI becomes less devastating. ... Type 2 Mis are treated by treating the underlying cause, so ...

US11835529B1 - Plasma thermograms for diagnosis and treatment ...

https://patents.google.com/patent/US11835529B1/en
... (type 1) MI only (2-7). While recommendations exist for the treatment of non-thrombotic (e.g., type 2) myocardial injury, randomized clinical trials to ...

Apolipoprotein B, Residual Cardiovascular Risk After Acute ...

https://news.google.com/__i/rss/rd/articles/CBMiQWh0dHBzOi8vd3d3LmFoYWpvdXJuYWxzLm9yZy9kb2kvMTAuMTE2MS9DSVJDVUxBVElPTkFIQS4xMjEuMDU3ODA30gEA?oc=5
Jun 30, 2022 ... On treatment with the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab, achieved levels of apolipoprotein B convey information ...

AI vs. Machine Learning: How Do They Differ? | Google Cloud

https://cloud.google.com/learn/artificial-intelligence-vs-machine-learning
ML and explore how these two innovative concepts are related and what makes them different from each other. New customers get up to $300 in free credits to ...

US10973836B2 - Methods of treating heart failure with reduced ...

https://patents.google.com/patent/US10973836B2/en
... myocardial infarction within 7 days from initiation of treatment with ... treat established HFrEF in patients with and without Type 2 diabetes. Sodium ...

The promise of new anti-obesity therapies arising from knowledge of ...

https://news.google.com/__i/rss/rd/articles/CBMiMmh0dHBzOi8vd3d3Lm5hdHVyZS5jb20vYXJ0aWNsZXMvczQxNTc0LTAyMi0wMDcxNi0w0gEA?oc=5/
Jul 28, 2022 ... Cooiman, M. I. et al. ... Brandt, S. J., Götz, A., Tschöp, M. H. & Müller, T. D. Gut hormone polyagonists for the treatment of type 2 diabetes.

A randomized placebo-controlled clinical trial for pharmacological ...

https://news.google.com/__i/rss/rd/articles/CBMiMmh0dHBzOi8vd3d3Lm5hdHVyZS5jb20vYXJ0aWNsZXMvczQxNDY3LTAyMi0zMTI0OS050gEA?oc=5
Jun 18, 2022 ... Elevations in plasma branched-chain amino acid (BCAA) levels associate with insulin resistance and type 2 diabetes (T2D).

Google Maps

https://maps.google.com/
Find local businesses, view maps and get driving directions in Google Maps.

Fitbit Inspire 3 | Health & fitness tracker

https://store.google.com/product/fitbit_inspire_3?hl=en-US
... Metrics like skin temperature & blood oxygen, plus get daily scores that show what kind of workout you're ready for and how well you're managing stress.